Medtronic wins $101M in patent lawsuit against NuVasive

A U.S. District Court has ruled competitor NuVasive must pay the Minnesota-based medical device maker more than $100 million in damages for infringing on three of its patents.
Author:
Publish date:

A U.S. District Court has ruled competitor NuVasive must pay the Minnesota-based medical device maker more than $100 million in damages for infringing on three of its patents.

Next Up

Related

Medtronic loses appeal of patent infringement case

Medtronic says it is evaluating its next step after a court rejected the company's appeal of a $74 million patent infringement ruling. The ruling could eventually force Medtronic to stop making one of its heart valves if a competitor - Edwards Lifesciences - seeks an injunction.